| Literature DB >> 25049669 |
Mingoo Kim1, Heewon Seo1, Yohan Choi1, Jangsoo Shim1, Heebal Kim1, Chang-Kyu Lee1, Hakhyun Ka1.
Abstract
During embryo implantation in pigs, the uterine endometrium undergoes dramatic morphological and functional changes accompanied with dynamic gene expression. Since the greatest amount of embryonic losses occur during this period, it is essential to understand the expression and function of genes in the uterine endometrium. Although many reports have studied gene expression in the uterine endometrium during the estrous cycle and pregnancy, the pattern of global gene expression in the uterine endometrium in response to the presence of a conceptus (embryo/fetus and associated extraembryonic membranes) has not been completely determined. To better understand the expression of pregnancy-specific genes in the endometrium during the implantation period, we analyzed global gene expression in the endometrium on day (D) 12 and D15 of pregnancy and the estrous cycle using a microarray technique in order to identify differentially expressed endometrial genes between D12 of pregnancy and D12 of the estrous cycle and between D15 of pregnancy and D15 of the estrous cycle. Results showed that the global pattern of gene expression varied with pregnancy status. Among 23,937 genes analyzed, 99 and 213 up-regulated genes and 92 and 231 down-regulated genes were identified as differentially expressed genes (DEGs) in the uterine endometrium on D12 and D15 of pregnancy compared to D12 and D15 of the estrous cycle, respectively. Functional annotation clustering analysis showed that those DEGs included genes involved in immunity, steroidogenesis, cell-to-cell interaction, and tissue remodeling. These findings suggest that the implantation process regulates differential endometrial gene expression to support the establishment of pregnancy in pigs. Further analysis of the genes identified in this study will provide insight into the cellular and molecular bases of the implantation process in pigs.Entities:
Keywords: Endometrium; Implantation; Microarray); Pig; Uterus
Year: 2012 PMID: 25049669 PMCID: PMC4092994 DOI: 10.5713/ajas.2012.12076
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Figure 1Volcano plot images for the comparative analysis of endometrial gene expression on day (D) 12 of pregnancy to D12 of the estrous cycle (A) and on D15 of pregnancy to D15 of the estrous cycle (B) in pigs. The X axis represents the average log_2 (fold-change), and the Y axis represents the -log (p-value) with base 10. Location in the upper left shaded area implies down-regulation; location in the upper right shaded area implies up-regulation. Cutoff values were below p<0.05 (horizontal line) and above an average two-fold change (vertical lines).
Figure 2Functional annotation charts showing distribution of ontological analysis of up-regulated (A) and down-regulated genes (B) in the uterine endometrium on day (D) 12 of pregnancy compared with those on D12 of the estrous cycle, and up-regulated (C) and down-regulated genes (D) on D15 of pregnancy compared with those on D15 of the estrous cycle. Biological terms were identified by genes with respect to biological process at level one through DAVID. Gene ontology terms or biological features of differently expressed genes and the number of genes in each category are indicated.
List of top 30 genes up-regulated in the uterine endometrium on day (D) 12 of pregnancy compared to genes on D12 of the estrous cycle by average fold change
| Probe set ID | Average log_2(Fold change) | Gene symbol | Gene title | RefSeq transcript ID |
|---|---|---|---|---|
| Ssc.12.1.S1_at | 5.1138 | Sulfotransferase family 1E, estrogen-preferring, member 1 | NM_213992 | |
| Ssc.31161.1.A1_at | 4.2407 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | NM_025003 | |
| Ssc.7637.1.A1_at | 4.0102 | LIM and calponin homology domains 1 | NM_001112717 | |
| Ssc.17508.2.A1_at | 3.9781 | Regulator of calcineurin 2 | NM_005822 | |
| Ssc.3102.2.A1_at | 3.8907 | Lysophosphatidic acid receptor 3 | NM_012152 | |
| Ssc.3102.1.S1_at | 3.8637 | Lysophosphatidic acid receptor 3 | NM_001162402 | |
| Ssc.9019.1.A1_at | 3.8489 | Natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) | NM_000908 | |
| Ssc.7890.1.S1_at | 3.3443 | Chromosome 5 open reading frame 23 | NM_024563 | |
| Ssc.27625.1.S1_at | 2.9314 | Gap junction protein, beta 5, 31.1kDa | NM_005268 | |
| Ssc.14085.1.A1_at | 2.8601 | Leucine rich repeat transmembrane neuronal 3 | NM_178011 | |
| Ssc.18819.1.A1_at | 2.8266 | Synaptotagmin XIII | NM_020826 | |
| Ssc.29244.1.A1_at | 2.6149 | Sortilin-related VPS10 domain containing receptor 3 | NM_014978 | |
| Ssc.12902.1.A1_at | 2.3709 | Solute carrier family 22 (organic cation transporter), member 2 | NM_003058 | |
| Ssc.21585.2.S1_at | 2.3324 | Ubiquitin protein ligase E3 component n-recognin 7 (putative) | NM_001100417 | |
| Ssc.12523.1.A1_at | 2.3272 | Chloride intracellular channel 4 | NM_013943 | |
| Ssc.15886.1.S1_at | 2.3001 | Caspase 3, apoptosis-related cysteine peptidase | NM_214131 | |
| Ssc.7864.1.A1_at | 2.1904 | Interleukin 1 receptor accessory protein | NM_002182 | |
| Ssc.18027.1.S1_at | 2.1855 | BTB (POZ) domain containing 3 | NM_014962 | |
| Ssc.6441.2.S1_at | 2.1576 | Dehydrogenase/reductase (SDR family) member 7 | NM_016029 | |
| Ssc.8552.3.S1_a_at | 2.1220 | Glycoprotein, alpha-galactosyltransferase 1 | NM_213810 | |
| Ssc.21460.1.A1_at | 1.9430 | Cellular repressor of E1A-stimulated genes 1 | NM_003851 | |
| Ssc.13221.1.A1_at | 1.8729 | Pyruvate carboxylase | NM_000920 | |
| Ssc.4999.1.S1_at | 1.8630 | Arginine vasopressin-induced 1 | NM_021732 | |
| Ssc.14304.1.A1_at | 1.8514 | Calsyntenin 2 | NM_022131 | |
| Ssc.15923.1.A1_at | 1.8044 | Fibroblast growth factor 7 | AF217463.1 | |
| Ssc.30862.1.S1_at | 1.8001 | DnaJ (Hsp40) homolog, subfamily B, member 9 | NM_012328 | |
| Ssc.31013.2.S1_at | 1.7794 | Potassium channel tetramerisation domain containing 3 | NM_016121 | |
| Ssc.12056.1.A1_at | 1.7746 | Lysyl oxidase-like 4 | NM_032211 | |
| Ssc.24450.1.S1_at | 1.7716 | Coagulation factor XIII, B polypeptide | NM_001994 | |
| Ssc.12412.1.A1_at | 1.7315 | Stromal cell-derived factor 2-like 1 | NM_022044 |
List of top 30 genes down-regulated in the uterine endometrium on day (D) 12 of pregnancy compared to genes on D12 of the estrous cycle by average fold change
| Probe set ID | Average log_2(Fold change) | Gene symbol | Gene title | RefSeq transcript ID |
|---|---|---|---|---|
| Ssc.10837.1.A1_at | −3.994277 | Roundabout, axon guidance receptor, homolog 1 (Drosophila) | NM_002941 | |
| Ssc.15850.1.S1_a_at | −3.892519 | T cell receptor alpha locus | NW_001838110.1 | |
| Ssc.16377.2.A1_at | −3.697358 | Glutathione S-transferase alpha 3 | NM_000847 | |
| Ssc.3904.1.S1_at | −2.781738 | Ribosomal protein S6 kinase, 90kDa, polypeptide 6 | NM_014496 | |
| Ssc.16767.1.S1_at | −2.76431 | Heterogeneous nuclear ribonucleoprotein L-like | NM_001005335 | |
| Ssc.338.1.S1_at | −2.656394 | Mucin 5AC, oligomeric mucus/gel-forming | NM_017511.1 | |
| Ssc.22190.1.S1_at | −2.632552 | Adherens junctions associated protein 1 | NM_001042478 | |
| Ssc.8621.1.A1_at | −2.490124 | Protein kinase, cAMP-dependent, catalytic, Beta | NM_002731 | |
| Ssc.23849.1.A1_at | −2.457561 | Solute carrier family 2 (facilitated glucose transporter), member 2 | NM_000340 | |
| Ssc.25254.1.S1_at | −2.378661 | Ras homolog gene family, member J | NM_020663 | |
| Ssc.21224.1.A1_at | −2.352619 | Keratin 7 | NM_005556 | |
| Ssc.6556.2.A1_at | −2.344349 | Gamma-aminobutyric acid (GABA) A receptor, alpha 5 | NM_000810 | |
| Ssc.27912.1.S1_at | −2.205287 | Zinc finger protein 608 | NM_020747 | |
| Ssc.24434.1.S1_at | −2.16435 | Chromosome 14 open reading frame 145 | NM_152446.3 | |
| Ssc.26326.1.A1_at | −2.134067 | Cytochrome P450 3A46 | NM_001134824 | |
| Ssc.11260.1.A1_at | −2.124412 | Glutathione S-transferase alpha 1 | NM_145740 | |
| Ssc.8053.1.S1_at | −1.953481 | Polymerase (DNA directed), lambda | NM_013274 | |
| Ssc.2618.1.S1_at | −1.827725 | MAM domain containing 4 | NM_206920 | |
| Ssc.5641.1.S1_at | −1.80541 | Ankyrin 2, neuronal | NM_001127493 | |
| Ssc.18992.1.A1_at | −1.784956 | Ankyrin repeat domain 6 | NM_014942 | |
| Ssc.30445.1.A1_at | −1.761477 | Anaplastic lymphoma receptor tyrosine Kinase | NM_004304 | |
| Ssc.27318.1.S1_at | −1.757688 | Keratin 7 | NM_005556 | |
| Ssc.30532.1.A1_at | −1.725776 | X-ray repair complementing defective repair in Chinese hamster cells 2 | NM_005431 | |
| Ssc.27626.1.S1_at | −1.719731 | EGF-like-domain, multiple 6 | NM_015507 | |
| Ssc.12223.1.A1_at | −1.690582 | Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | NM_012411 | |
| Ssc.336.1.S1_at | −1.631299 | Ubiquitin specific peptidase 18 | NM_213826 | |
| Ssc.15708.1.S1_at | −1.621459 | Hemoglobin, zeta | NM_005332 | |
| Ssc.7243.1.A1_at | −1.619644 | Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | NM_001009580 | |
| Ssc.21162.1.S1_s_at | −1.609334 | Interferon regulatory factor 7 | NM_001097428 | |
| Ssc.286.1.S1_s_at | −1.553267 | Inflammatory response protein 6 | NM_213817 |
List of top 30 genes up-regulated in the uterine endometrium on day (D) 15 of pregnancy compared to genes on D15 of the estrous cycle by average fold change
| Probe set ID | Average log_2(Fold change) | Gene symbol | Gene title | RefSeq transcript ID |
|---|---|---|---|---|
| Ssc.28494.1.S1_at | 3.9383217 | RAB5B, member RAS oncogene family | NM_002868 | |
| Ssc.18273.1.A1_at | 3.9374428 | Membrane associated guanylate kinase, WW and PDZ domain containing 1 | NM_173515 | |
| Ssc.22734.1.A1_at | 3.505833 | ER degradation enhancer, mannosidase alpha- like 3 | NM_025191 | |
| Ssc.6392.1.S1_at | 3.3603669 | Neurotrimin | NM_001144058.1 | |
| Ssc.25740.1.A1_at | 3.3474057 | A kinase (PRKA) anchor protein 1 | NM_003488 | |
| Ssc.9329.1.A1_at | 3.0693123 | Protein tyrosine phosphatase-like A domain containing 2 | NM_001010915 | |
| Ssc.10593.2.A1_at | 3.0355328 | Interferon-induced protein 44-like | NM_006820 | |
| Ssc.11925.1.A1_at | 2.8589389 | Sel-1 suppressor of lin-12-like (C. Elegans) | NM_005065 | |
| Ssc.25678.1.S1_at | 2.8213114 | Synaptotagmin I | NM_005639 | |
| Ssc.12809.5.A1_at | 2.7832047 | Hemoglobin, alpha 2; hemoglobin, alpha 1 | NM_000517 | |
| Ssc.7455.1.A1_at | 2.7595911 | Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | NM_015423 | |
| Ssc.7682.1.A1_at | 2.6842858 | Oxysterol binding protein-like 9 | NM_024586 | |
| AFFX-Ss_18SrRNA_at | 2.6236143 | AFFX-Ss_18SrRNA | Null | |
| Ssc.21585.2.S1_at | 2.5961034 | Ubiquitin protein ligase E3 component n-recognin 7 (putative) | NM_001100417 | |
| Ssc.13473.1.A1_at | 2.5538991 | UDP-glucose ceramide glucosyltransferase | NM_003358 | |
| Ssc.27407.1.A1_at | 2.5424531 | Nuclear receptor interacting protein 1 | NM_003489 | |
| Ssc.3975.2.A1_at | 2.4775446 | Serine/threonine kinase 38 like | NM_015000.3 | |
| Ssc.28192.1.A1_at | 2.4555041 | Family with sequence similarity 153, member A | NM_173663 | |
| Ssc.20353.1.S1_at | 2.3855645 | Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | NR_002819.2 | |
| Ssc.11870.1.A1_at | 2.2433352 | Nuclear receptor interacting protein 1 | NM_003489 | |
| Ssc.17508.2.A1_at | 2.2266604 | Regulator of calcineurin 2 | NM_005822 | |
| Ssc.8143.2.A1_at | 2.1943771 | Rap guanine nucleotide exchange factor (GEF) 2 | NM_014247 | |
| Ssc.17152.2.A1_at | 2.1849978 | Coenzyme Q2 homolog, prenyltransferase (Yeast) | NM_015697 | |
| Ssc.27130.1.A1_at | 2.1615496 | Solute carrier family 25, member 36 | NM_001104647 | |
| Ssc.3325.3.S1_at | 2.1184436 | Exostoses (multiple) 1 | NM_000127 | |
| Ssc.22645.1.S1_at | 2.0685056 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 | NM_014829 | |
| Ssc.6175.1.S1_at | 2.0623846 | Ligand dependent nuclear receptor corepressor | NM_032440 | |
| Ssc.13601.1.A1_at | 1.8954884 | Myosin IB | NM_001130158 | |
| Ssc.24402.1.S1_at | 1.8920959 | Coiled-coil domain containing 76 | NM_019083 | |
| Ssc.27133.1.A1_at | 1.8789606 | Transmembrane protein 68 | NM_152417 |
List of top 30 genes down-regulated in the uterine endometrium on day (D) 15 of pregnancy compared to genes on D15 of the estrous cycle by average fold change
| Probe set ID | Average log_2(Fold change) | Gene symbol | Gene title | RefSeq transcript ID |
|---|---|---|---|---|
| Ssc.25087.1.S1_at | −4.665941 | DnaJ (Hsp40) homolog, subfamily C, member 13 | NM_015268 | |
| Ssc.2015.2.S1_at | −4.469763 | Zinc finger protein 449 | NM_152695 | |
| Ssc.7817.1.A1_at | −4.302148 | Neuropilin (NRP) and tolloid (TLL)-like 1 | NM_138966 | |
| Ssc.23424.1.A1_at | −4.072875 | Dystrobrevin, alpha | NM_001128175 | |
| Ssc.8989.1.A1_at | −3.882042 | Periphilin 1 | NM_016488 | |
| Ssc.21088.2.S1_at | −3.009555 | Cleavage stimulation factor, 3′ pre-RNA, subunit 1, 50kDa | NM_001033521 | |
| Ssc.9834.2.S1_at | −2.875995 | Sn36_F05.f sn Sus scrofa cDNA | CB471302.1 | |
| Ssc.1600.1.A1_at | −2.684489 | Ribosomal modification protein rimK-like family member B | NM_020734.2 | |
| Ssc.1600.1.A1_a_at | −2.616954 | Ribosomal modification protein rimK-like family member B | NM_020734.2 | |
| Ssc.27385.1.S1_at | −2.580643 | Retinol binding protein 7, cellular | NM_001145222 | |
| Ssc.668.1.S1_at | −2.543521 | Parathyroid hormone | NM_214401 | |
| Ssc.958.1.S1_at | −2.543376 | Aldolase B, fructose-bisphosphate | NM_000035 | |
| Ssc.27953.1.S1_at | −2.289442 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | NM_005933 | |
| Ssc.21468.2.A1_at | −2.194019 | La ribonucleoprotein domain family, member 1 | NM_015315 | |
| Ssc.30456.1.A1_at | −2.155805 | Coiled-coil domain containing 135 | NM_032269 | |
| Ssc.27345.1.S1_at | −2.107692 | 940760 MARC 4PIG Sus scrofa cDNA | CN153625.1 | |
| Ssc.7219.1.A1_at | −1.926105 | ELKS/RAB6-interacting/CAST family member 2 | NM_015576 | |
| Ssc.22791.1.A1_at | −1.922899 | Early endosome antigen 1 | NM_003566 | |
| Ssc.7672.1.A1_at | −1.847485 | Capping protein (actin filament) muscle Z-line, beta | NM_004930 | |
| Ssc.25130.1.A1_at | −1.83943 | Chromosome 6 open reading frame 98 | NM_001099267 | |
| Ssc.30379.1.A1_at | −1.831398 | Armadillo repeat containing 3 | NM_173081 | |
| Ssc.7191.1.A1_at | −1.805 | LSM14A, SCD6 homolog A (S. Cerevisiae) | NM_001114093 | |
| Ssc.2589.1.S1_at | −1.790171 | Troponin I type 3 (cardiac) | NM_001098599 | |
| Ssc.23948.1.A1_at | −1.727051 | Dynein, cytoplasmic 1, intermediate chain 2 | NM_001378 | |
| Ssc.8133.1.A1_at | −1.725898 | Glycoprotein M6B | NM_001001994 | |
| Ssc.28842.1.A1_at | −1.685047 | Coiled-coil domain containing 113 | NM_014157 | |
| Ssc.7917.1.A1_at | −1.680845 | MI-P-E6-ahn-e-09-1-UM.s1 MI-P-E6 Sus scrofa cDNA clone | BQ599768.1 | |
| Ssc.29910.1.A1_at | −1.633574 | Myotubularin related protein 2 | NM_016156 | |
| Ssc.6616.1.S1_at | −1.629585 | Chromosome 1 open reading frame 92 | NM_144702 | |
| Ssc.28950.1.A1_at | −1.627009 | Exocyst complex component 6 | NM_019053.4 |
Functional annotation clusters of up-regulated genes in uterine endometrium on D12 of pregnancy compared with those on D12 of the estrous cycle
| Annotation cluster | Enrichment score | Biological terms |
|---|---|---|
| 1 | 2.56 | Membrane fraction (12), cell fraction (14), insoluble fraction (12) |
| 2 | 1.04 | Endoplasmic reticulum part (6), endoplasmic reticulum membrane (5), endoplasmic reticulum (10), nuclear envelope-endoplasmic reticulum network (5), microsome (4), vesicular fraction (4), organelle membrane (9), endomembrane system (6) |
| 3 | 0.88 | Blood vessel morphogenesis (4), blood vessel development (4), vasculature development (4) |
| 4 | 0.86 | Cellular macromolecule catabolic process (9), proteolysis (11), macromolecule catabolic process (9), proteolysis involved in cellular protein catabolic process (7), cellular protein catabolic process (7), protein catabolic process (7), ubiquitin- protein ligase activity (3), small conjugating protein ligase activity (3), ligase activity, forming carbon-nitrogen bonds (3), ubiquitin-dependent protein catabolic process (3), modification-dependent macromolecule catabolic process (6), acid- amino acid ligase activity (3), modification-dependent protein catabolic process (6) |
| 5 | 0.80 | Intracellular organelle lumen (14), organelle lumen (14), nuclear lumen (10), membrane-enclosed lumen (14), nucleoplasm (8) |
| 6 | 0.72 | Proteolysis (11), metalloendopeptidase activity (3), endopeptidase activity (5), negative regulation of apoptosis (5), negative regulation of programmed cell death(5), negative regulation of cell death (5), metallopeptidase activity (3), peptidase activity, acting on L-amino acid peptides (5), peptidase activity (5), regulation of apoptosis (6), regulation of programmed cell death (6), regulation of cell death (6) |
| 7 | 0.72 | Phosphatase activity (5), phosphoprotein phosphatase activity (4), phosphate metabolic process (9), dephosphorylation (4), phosphorus metabolic process (9), protein amino acid dephosphorylation (3), protein serine/threonine kinase activity(3), phosphorylation (5), protein amino acid phosphorylation (5), protein kinase activity (3) |
| 8 | 0.71 | Positive regulation of multicellular organismal process (4), positive regulation of cell proliferation (5), regulation of growth (4) |
| 9 | 0.65 | Cell cycle (8), mitotic cell cycle (5), cell cycle process (5), cell cycle phase (4) |
| 10 | 0.65 | Glycosaminoglycan binding (3), polysaccharide binding (3), pattern binding (3), carbohydrate binding (3) |
Top ten of annotation clusters identified by official gene symbols of up-regulated gene list on D12 of pregnancy compared with those on D12 of the estrous cycle through DAVID.
Enrichment score represents significance of each cluster annotation and the relatedness of the terms and the genes associated with terms. Enrichment score is calculated by overall EASE scores (the modified Fisher extract p value) of each term member.
The gene ontology (GO) terms are group of terms having similar biological meaning with respect to biological process, cellular component, and molecular function. GO functional annotation term (FAT) was used for the analysis because GO term cannot universally define the specificity of a given term. The number in parenthesis indicate the number of differentially expressed genes contribute to the clustered term.
Functional annotation clusters of down-regulated genes in uterine endometrium on D12 of pregnancy compared with those on D12 of the estrous cycle
| Annotation cluster | Enrichment score | Biological terms |
|---|---|---|
| 1 | 2.04 | Plasma membrane part (22), integral to plasma membrane (11), intrinsic to plasma membrane (11) |
| 2 | 2.03 | Cell adhesion (11), biological adhesion (11), cell-cell adhesion (4) |
| 3 | 1.50 | Leukocyte activation (7), cell activation (7), lymphocyte activation (6), T cell activation (4), immune effector process (4), regulation of leukocyte activation (4), regulation of cell activation (4), leukocyte mediated immunity (3), cell surface (5), positive regulation of response to stimulus (4), positive regulation of immune system process (4), immune response (7), external side of plasma membrane (3) |
| 4 | 1.48 | Immune system development (7), hemopoiesis (6), hemopoietic or lymphoid organ development (6), myeloid cell differentiation (3), protein homodimerization activity (4), nucleoplasm part (3) |
| 5 | 1.46 | Cell junction (7), adherens junction (4), anchoring junction 4) |
| 6 | 1.45 | Biopolymer glycosylation (4), glycoprotein biosynthetic process (4), glycoprotein metabolic process (4), glycosylation (4), protein amino acid glycosylation (4) |
| 7 | 0.98 | Apoptosis (7), programmed cell death (7), cell death (7), death (7), negative regulation of cell proliferation (4) |
| 8 | 0.83 | DNA metabolic process (8), response to DNA damage stimulus (5), DNA repair (4), cellular response to stress (5), DNA binding (7) |
| 9 | 0.83 | Induction of apoptosis (5), induction of programmed cell death (5), positive regulation of apoptosis (5), positive regulation of programmed cell death (5), positive regulation of cell death (5), regulation of apoptosis (7), regulation of programmed cell death (7), regulation of cell death (7) |
| 10 | 0.76 | Response to ionizing radiation (3), response to radiation (3), response to abiotic stimulus (3) |
Top ten of annotation clusters identified by official gene symbols of up-regulated gene list on D15 of pregnancy compared with those on D15 of the estrous cycle.
Enrichment score represents significance of each cluster annotation and the relatedness of the terms and the genes associated with terms. Enrichment score is calculated by overall EASE scores (the modified Fisher extract p value) of each term member.
The gene ontology (GO) terms are group of terms having similar biological meaning with respect to biological process, cellular component, and molecular function. GO functional annotation term (FAT) was used for the analysis because GO term cannot universally define the specificity of a given term. The number in parenthesis indicate the number of differentially expressed genes contribute to the clustered term.
Functional annotation clusters of up-regulated genes in uterine endometrium on D15 of pregnancy compared with those on D15 of the estrous cycle
| Annotation cluster | Enrichment score | Biological terms |
|---|---|---|
| 1 | 3.46 | Nuclear speck (7), nuclear body (8), RNA splicing (9) |
| 2 | 2.21 | Nucleotide binding (30), purine ribonucleotide binding (25), AT P binding (21), ribonucleotide binding (25), purine nucleotide binding (25), adenyl ribonucleotide binding (21), adenyl nucleotide binding (21), purine nucleoside binding (21), nucleoside binding (21) |
| 3 | 2.12 | Nuclear body (8), nucleoplasm part (12), nucleoplasm (15), membrane-enclosed lumen (24), nuclear lumen (20), intracellular organelle lumen (23), organelle lumen (23), nucleolus (9) |
| 4 | 1.51 | RNA splicing (9), mrna metabolic process (9), RNA processing (11), mrna processing (8), spliceosome assembly (3), RNA splicing, via transesterification reactions (5), RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (5), nuclear mrna splicing, via spliceosome (5), RNA binding (11), ribonucleoprotein complex assembly (3), ribonucleoprotein complex biogenesis (4), cellular macromolecular complex assembly (5), cellular macromolecular complex subunit organization (5) |
| 5 | 1.15 | Nuclear body (8), nuclear export (4), nucleocytoplasmic transport (4), nuclear transport (4), mrna transport (3), establishment of RNA localization (3), nucleic acid transport (3), RNA transport (3), RNA localization (3), nucleobase, nucleoside, nucleotide and nucleic acid transport (3), intracellular transport (8) |
| 6 | 1.06 | Receptor-mediated endocytosis (4), membrane organization (8), membrane invagination (4), endocytosis (4), vesicle-mediated transport (6) |
| 7 | 0.96 | Helicase activity (6), ATP-dependent helicase activity (3), purine NTP-dependent helicase activity (3), atpase activity, coupled (4), atpase activity (4) |
| 8 | 0.95 | Enzyme binding (8), protein kinase binding (4), kinase binding(4) |
| 9 | 0.94 | Macromolecular complex assembly (11), macromolecular complex subunit organization (11), protein complex assembly (8), protein complex biogenesis (8), cellular macromolecular complex assembly (5), cellular macromolecular complex subunit organization (5), protein oligomerization (3) |
| 10 | 0.75 | Protein serine/threonine kinase activity (7), enzyme linked receptor protein signaling pathway (6), phosphate metabolic process (11), phosphorus metabolic process (11), protein kinase activity (8), protein amino acid phosphorylation (8), phosphorylation (9) |
Top ten of annotation clusters identified by official gene symbols of up-regulated gene list on D12 of pregnancy compared with those on D12 of the estrous cycle.
Enrichment score represents significance of each cluster annotation and the relatedness of the terms and the genes associated with terms. Enrichment score is calculated by overall EASE scores (the modified Fisher extract p value) of each term member.
The gene ontology (GO) terms are group of terms having similar biological meaning with respect to biological process, cellular component, and molecular function. GO functional annotation term (FAT) was used for the analysis because GO term cannot universally define the specificity of a given term. The number in parenthesis indicate the number of differentially expressed genes contribute to the clustered term.
Functional annotation clusters of down-regulated genes in uterine endometrium on D15 of pregnancy compared with those on D15 of the estrous cycle
| Annotation cluster | Enrichment score | Biological terms |
|---|---|---|
| 1 | 1.68 | Adenyl ribonucleotide binding (15), purine ribonucleotide binding (17), purine nucleotide binding (17), ribonucleotide binding (17), nucleoside binding (15), adenyl nucleotide binding (15), purine nucleoside binding (15), ATP binding (14), nucleotide binding (18) |
| 2 | 1.50 | Cytoskeletal part (11), microtubule cytoskeleton (7), intracellular non-membrane- bounded organelle (18), non-membrane- bounded organelle (18), centrosome (4), cytoskeleton (13), microtubule organizing center (4) |
| 3 | 1.50 | Cytoskeletal part (11), dynein complex (3), microtubule associated complex (4), microtubule-based movement (4), microtubule cytoskeleton (7), motor activity (3), microtubule motor activity (3), microtubule (4), microtubule-based process (4) |
| 4 | 1.20 | Cytoskeletal part (11), regulation of actin filament length (3), regulation of cellular component size (5), regulation of actin cytoskeleton organization (3), regulation of actin filament-based process (3), regulation of organelle organization (4), actin cytoskeleton (4), cytoskeletal protein binding (6), regulation of cytoskeleton organization (3), actin binding (4) |
| 5 | 1.17 | Regulation of neuron differentiation (4), regulation of neurogenesis (4), regulation of nervous system development (4), regulation of cell development (4), neuron differentiation (4) |
| 6 | 0.92 | Protein amino acid dephosphorylation (4), dephosphorylation (4), phosphorus metabolic process (9), phosphoprotein phosphatase activity (4), phosphate metabolic process (9), protein tyrosine phosphatase activity (3), phosphatase activity (4), protein kinase activity (5), protein serine/threonine kinase activity (4), protein amino acid phosphorylation (5), phosphorylation (5) |
| 7 | 0.84 | Central nervous system neuron axonogenesis (3), central nervous system neuron development (3), central nervous system neuron differentiation (3), cell projection organization (5), cell motion (5), axonogenesis (3), cell morphogenesis involved in neuron differentiation (3), neuron projection morphogenesis (3), cell projection morphogenesis (3), cell morphogenesis involved in differentiation (3), cell part morphogenesis (3), neuron differentiation (4), neuron projection development (3), cell morphogenesis (3), cellular component morphogenesis (3), neuron development (3) |
| 8 | 0.82 | Regulation of synaptic transmission (3), regulation of transmission of nerve impulse (3), regulation of neurological system process (3), regulation of system process (4) |
| 9 | 0.75 | Cell projection organization (5), cytoskeletal protein binding (6), cytoskeleton organization (3) |
| 10 | 0.71 | Learning or memory (3), neurological system process (10), behavior (5), cognition (4) |
Top ten of annotation clusters identified by official gene symbols of up-regulated gene list on D15 of pregnancy compared with those on D15 of the estrous cycle.
Enrichment score represents significance of each cluster annotation and the relatedness of the terms and the genes associated with terms. Enrichment score is calculated by overall EASE scores (the modified Fisher extract p value) of each term member.
The gene ontology (GO) terms are group of terms having similar biological meaning with respect to biological process, cellular component, and molecular function. GO functional annotation term (FAT) was used for the analysis because GO term cannot universally define the specificity of a given term. The number in parenthesis indicate the number of differentially expressed genes contribute to the clustered term.